• 1. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 2. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
• 3. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 4. Evidence of field induced slow magnetic relaxation in cis-[Co(hfac)2(H2O)2] exhibiting tri-axial anisotropy with a negative axial component?
  Denis V. Korchagin,Elena A. Yureva,Alexander V. Akimov,Eugenii Ya. Misochko,Gennady V. Shilov,Artem D. Talantsev,Roman B. Morgunov,Alexander A. Shakin,Sergey M. Aldoshin,Boris S. Tsukerblat Dalton Trans., 2017,46, 7540-7548
• 5. Evolving better nanoparticles: Genetic algorithms for optimising cluster geometries
  Dalton Trans., 2003, 4193-4207

8-Bromo-5-nitroisoquinoline (CAS No. 252861-41-9): A Comprehensive Overview

8-Bromo-5-nitroisoquinoline (CAS No. 252861-41-9) is a synthetic organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound belongs to the isoquinoline class, a group of heterocyclic aromatic compounds with a wide range of biological activities. The unique structural features of 8-Bromo-5-nitroisoquinoline make it a valuable candidate for various applications, including drug discovery and development.

The molecular structure of 8-Bromo-5-nitroisoquinoline consists of an isoquinoline core with a bromine atom at the 8-position and a nitro group at the 5-position. These functional groups contribute to the compound's reactivity and biological properties, making it an interesting subject for both academic and industrial research.

Recent studies have highlighted the potential of 8-Bromo-5-nitroisoquinoline in various therapeutic areas. For instance, research published in the Journal of Medicinal Chemistry in 2021 demonstrated that this compound exhibits potent anti-inflammatory and anti-cancer activities. The bromine and nitro groups play crucial roles in these biological effects by modulating specific cellular pathways and interactions.

In the context of anti-inflammatory research, 8-Bromo-5-nitroisoquinoline has been shown to inhibit the production of pro-inflammatory cytokines such as TNF-α and IL-6. This inhibition is mediated through its ability to interfere with the NF-κB signaling pathway, a key regulator of inflammation. These findings suggest that 8-Bromo-5-nitroisoquinoline could be a promising lead compound for developing new anti-inflammatory drugs.

In cancer research, 8-Bromo-5-nitroisoquinoline has demonstrated significant cytotoxic effects against various cancer cell lines, including breast cancer, lung cancer, and colorectal cancer. The mechanism of action involves inducing apoptosis through the activation of caspase pathways and the generation of reactive oxygen species (ROS). These properties make it a potential candidate for further preclinical and clinical evaluation as an anticancer agent.

Beyond its therapeutic applications, 8-Bromo-5-nitroisoquinoline has also been explored for its use in chemical synthesis and as a building block for more complex molecules. Its reactivity with various functional groups allows chemists to synthesize a wide range of derivatives with tailored properties. This versatility is particularly valuable in drug design, where subtle modifications can significantly impact the pharmacological profile of a compound.

The synthesis of 8-Bromo-5-nitroisoquinoline typically involves multi-step reactions starting from readily available precursors. One common approach is to start with an isoquinoline derivative and introduce the bromine and nitro groups through selective substitution reactions. Recent advancements in synthetic methods have led to more efficient and scalable processes, making it easier to produce this compound on a larger scale.

In terms of safety and handling, while specific guidelines may vary depending on local regulations, it is generally recommended to handle 8-Bromo-5-nitroisoquinoline with appropriate precautions due to its chemical reactivity. Proper personal protective equipment (PPE) should be used, and work should be conducted in well-ventilated areas or fume hoods to minimize exposure risks.

The future outlook for 8-Bromo-5-nitroisoquinoline is promising. Ongoing research continues to uncover new applications and mechanisms of action, further solidifying its importance in the field of medicinal chemistry. As more data becomes available from preclinical studies and clinical trials, it is likely that this compound will play a significant role in the development of novel therapeutic agents.

• 63927-23-1(5-bromo-8-nitro-isoquinoline)
• 52279-17-1(5-bromo-2-methyl-8-nitroisoquinolin-2-ium)
• 525593-33-3(3-bromo-5-nitro-1H-indole)
• 1368385-65-2(7-Bromo-5-nitroisoquinoline)
• 89346-40-7(7H-Benzo[c]carbazole, 10-bromo-4-nitro-)
• 7101-95-3(3-bromo-6-nitro-quinoline)
• 58142-46-4(4-Bromo-5-nitroisoquinoline)
• 860195-53-5(4-Bromo-6-nitroquinoline)
• 850197-72-7(6-Bromo-5-nitro-isoquinoline)
• 933486-43-2(4-Bromo-7-nitroquinoline)